1. Antibody–drug conjugate drug development: where are the challenges?. (June 2013) Authors: Wright, Laura; Baughman, Sharon; Wake, Ashleigh Journal: Bioanalysis Issue: Volume 5:Number 12(2013) Page Start: 1467 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Antibody–drug conjugate drug development: where are the challenges?. (June 2013) Authors: Wright, Laura; Baughman, Sharon; Wake, Ashleigh Journal: Bioanalysis Issue: Volume 5:Number 12(2013) Page Start: 1467 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Antibody–drug conjugate drug development: where are the challenges?. (June 2013) Authors: Wright, Laura; Baughman, Sharon; Wake, Ashleigh Journal: Bioanalysis Issue: Volume 5:Number 12(2013) Page Start: 1467 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Antibody–drug conjugate drug development: where are the challenges?. (June 2013) Authors: Wright, Laura; Baughman, Sharon; Wake, Ashleigh Journal: Bioanalysis Issue: Volume 5:Number 12(2013) Page Start: 1467 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Recommendations and requirements for the design of bioanalytical testing used in comparability studies for biosimilar drug development. (March 2011) Authors: Cai, Xiao-Yan; Gouty, Dominique; Baughman, Sharon; Ramakrishnan, MS; Cullen, Constance Journal: Bioanalysis Issue: Volume 3:Number 5(2011) Page Start: 535 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗